Impact Biomedical (IBO) EPS (Basic) (2022 - 2026)
Impact Biomedical's (IBO) quarterly EPS (Basic) came in at -$0.01 in Q2 2026, up 99.45% on a YoY basis from -$0.0 in Q2 2025, and up 69.36% quarter-over-quarter from -$0.02 in Q1 2026.
Powered by 
Analysis
Impact Biomedical (IBO) EPS (Basic) (2022 - 2026) Analysis & Trends
Impact Biomedical (IBO) has reported EPS (Basic) for 5 consecutive years, with -$0.01 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EPS (Basic) rose 99.45% year-over-year to -$0.01; the trailing twelve-month figure through Jun 2026 stood at -$0.17 (up 94.48% YoY), and the FY2024 full-year result was -$2.3, down 3099.51% from the prior year.
- EPS (Basic) grew to -$0.01 in Q2 2026 per IBO's latest filing, from -$0.02 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.37 in Q3 2024 and bottomed at -$2.52 in Q4 2024.
- Historically, EPS (Basic) has averaged -$0.24 across 5 years, with a median of -$0.03 in 2022.
- The widest YoY moves for EPS (Basic): up 2339.72% in 2024, down 12189.9% in 2024.
- Over 5 years, EPS (Basic) stood at -$0.05 in 2022, then soared by 57.02% to -$0.02 in 2023, then slumped by 12189.9% to -$2.52 in 2024, then jumped by 95.2% to -$0.12 in 2025, then soared by 94.64% to -$0.01 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.01, -$0.02, and -$0.12 for Q2 2026, Q1 2026, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -0.40 |
| 10 | Impact Biomedical | 49.63 Mn | 49.62 Mn | 2,000.00 | -0.01 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.01 |
| Mar 31, 2026 | -0.02 |
| Sep 30, 2025 | -0.12 |
| Jun 30, 2025 | -1.18 |
| Mar 31, 2025 | -0.11 |
| Dec 31, 2024 | -2.52 |
| Sep 30, 2024 | 0.37 |
| Jun 30, 2024 | -0.09 |
| Mar 31, 2024 | -0.10 |
| Dec 31, 2023 | -0.02 |
| Sep 30, 2023 | -0.02 |
| Jun 30, 2023 | -0.02 |
| Mar 31, 2023 | -0.01 |
| Dec 31, 2022 | -0.05 |
| Sep 30, 2022 | -0.03 |
| Jun 30, 2022 | 0.00 |